BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10962136)

  • 21. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant.
    Palmer JA; Lau TM; Hickey M; Simbah M; Rogers PA
    Hum Reprod; 1996 Oct; 11(10):2142-50. PubMed ID: 8943519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of irregular uterine bleeding and spotting associated with Norplant.
    Archer DF; Philput CA; Weber ME
    Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The measurement of endometrial perfusion in norplant users: a pilot study.
    Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
    Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on relationship between endometrium laminin expression and irregular uterine bleeding in Norplant users].
    Shi X; Han X; Weng J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):169-71. PubMed ID: 11775898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
    Hickey M; Dwarte D; Fraser IS
    Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the endometrial changes in Norplant users.
    Wan LS
    Ann N Y Acad Sci; 1997 Sep; 828():108-10. PubMed ID: 9329828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
    Faúndes A; Alvarez F; Brache V; Cochón L
    Hum Reprod; 1998 Jan; 13(1):188-91. PubMed ID: 9512255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone receptor in Norplant endometrium.
    Lau TM; Witjaksono J; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():90-4. PubMed ID: 8982750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding.
    Rogers PA; Lederman F; Plunkett D; Affandi B
    Hum Reprod; 2000 Aug; 15 Suppl 3():152-61. PubMed ID: 11041231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy.
    Chegini N; Luo X; Pan Q; Rhoton-Vlasak A; Archer DF
    Hum Reprod; 2007 Feb; 22(2):427-33. PubMed ID: 17095519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users.
    Marbaix E; Vekemans M; Galant C; Rigot V; Lemoine P; Dubois D; Picquet C; Henriet P; Twagirayezu P; Sufi S; Eeckhout Y; Courtoy PJ
    Hum Reprod; 2000 Aug; 15 Suppl 3():120-34. PubMed ID: 11041228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.
    Massai MR; Pavez M; Fuentealba B; Croxatto HB; d'Arcangues C
    Contraception; 2004 Jul; 70(1):47-54. PubMed ID: 15208052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The changes of sex steroid receptors and morphology in Norplant treated endometrium].
    Wang G; Zheng S; Fan Z
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):493-7. PubMed ID: 10806752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding.
    Rogers PA; Plunkett D; Affandi B
    Hum Reprod; 2000 Aug; 15 Suppl 3():78-84. PubMed ID: 11041224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precise measurements of intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use.
    Hickey M; Dwarte D; Fraser IS
    Hum Reprod; 1998 Nov; 13(11):3190-6. PubMed ID: 9853879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
    Chegini N; Rhoton-Vlasak A; Williams RS
    Fertil Steril; 2003 Sep; 80(3):564-70. PubMed ID: 12969699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium.
    Lau TM; Affandi B; Rogers PA
    Mol Hum Reprod; 1999 Jan; 5(1):57-63. PubMed ID: 10050663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B).
    Vincent AJ; Malakooti N; Zhang J; Rogers PA; Affandi B; Salamonsen LA
    Hum Reprod; 1999 Mar; 14(3):807-15. PubMed ID: 10221718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaginal bleeding patterns and the regularity in use of Norplant].
    Meng F; Fan H; Han L
    Zhonghua Yi Xue Za Zhi; 1996 May; 76(5):331-4. PubMed ID: 9206192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.